McGahan Keith M's Form 4 filing
Spectrum Pharmaceuticals Inc (SPPI) · filed Feb 1, 2023
- Accession no.
- 0000899243-23-003145
- Filed
- Feb 1, 2023
- Trade date
- Jan 30-31, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $39.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McGahan Keith MCIK 0001743778 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2023 | Common Stock, $0.001 par value | SSaleDisposed | −26,138 | $0.54 | −$14,114.52 | 686,887 | Direct | |
| Jan 31, 2023 | Common Stock, $0.001 par value | SSaleDisposed | −41,014 | $0.62 | −$25,428.68 | 645,873 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.